FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

Biocon Biologics and Civica Inc. not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, has inked a strategic ...

"There’s been a real shortage of these products, particularly since they share production with, for example, the diabetes and weight-loss products." Aspen is adding the ability to make pens and may ...

After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...

the diabetes and weight-loss products.” Aspen is adding the ability to make pens and may yet get rights to manufacturer insulin pens, Saad added. South Africa’s regulator has also been called ...